Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-04

FDA Approved: PRED FORTE — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Pred Forte (prednisolone acetate ophthalmic suspension) from Allergan, updating/expanding its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRED FORTE (Prednisolone acetate)

Snippet

SUPPL AP for PRED FORTE (PREDNISOLONE ACETATE)